HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral co-delivery nanoemulsion of 5-fluorouracil and curcumin for synergistic effects against liver cancer.

AbstractBACKGROUND:
A novel nanoemulsion (CU/FU-LN) was developed as an oral 5-fluorouracil and curcumin co-delivery system for synergistic efficacy against liver cancer.
METHODS:
MTT assay, confocal laser scanning microscope, and H&E staining were utilized to establish the efficacy and safety of CU/FU-LN.
RESULTS:
The AUC(0-t) of CU/FU-LN was 8.85-fold and 8.59-fold greater than those of CU and FU, respectively. The IC50 of CU/FU-LN was 4.6-fold and 4.9-fold lower than those of FU and CU in HepG2 cells, respectively. In vivo anti-tumor trials, the tumor inhibition rate was significantly elevated by CU/FU-LN (49.29%), compared 24.84% and 4.72% for FU and CU, respectively. Ki-67 immunohistochemical analysis revealed that CU/FU-LN had an obvious anti-proliferation effect. The IC50 of CU/FU-LN in L02 cells was 1.51-fold and 2.60-fold higher than those of CU and FU, respectively. Certain vital organs in the mice of the CU/FU-LN group showed markedly fewer lesions than those of the CU, FU, and CU+FU groups. The CU/FU-LN treatment caused no significant change in mouse body weight relative to the control group (P > 0.05).
CONCLUSIONS:
We successfully prepared a promising co-delivery platform for the synergistic treatment of liver cancer and it has a comparatively enhanced efficacy and mitigated toxicity.
AuthorsPu Guo, Chao Pi, Shijie Zhao, Shaozhi Fu, Hongru Yang, Xiaoli Zheng, Xiaomei Zhang, Ling Zhao, Yumeng Wei
JournalExpert opinion on drug delivery (Expert Opin Drug Deliv) Vol. 17 Issue 10 Pg. 1473-1484 (10 2020) ISSN: 1744-7593 [Electronic] England
PMID32749895 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Curcumin
  • Fluorouracil
Topics
  • Animals
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Curcumin (administration & dosage, pharmacology)
  • Fluorouracil (administration & dosage)
  • Hep G2 Cells
  • Humans
  • Liver Neoplasms (drug therapy)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: